Funds and ETFs Synthaverse S.A.

Equities

SVE

PLBMDLB00018

Pharmaceuticals

Market Closed - Warsaw S.E. 09:25:54 09/05/2024 pm IST 5-day change 1st Jan Change
4.81 PLN +2.45% Intraday chart for Synthaverse S.A. -2.83% +12.65%

ETFs positioned on Synthaverse S.A.

Name Weight AuM 1st Jan change Investor Rating
0.00% 0 M€ +4.02% -
Synthaverse SA formerly known as Biomed Lublin Wytwornia Surowic i Szczepionek SA is a Poland-based company operating in the Life Science industry, dealing primarily with the production of medicines. The Company focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The Company offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The Company supplies its products to 50 countries around the world.
More about the company
  1. Stock Market
  2. Equities
  3. SVE Stock
  4. Funds and ETFs Synthaverse S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW